ZA988162B - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. - Google Patents

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.

Info

Publication number
ZA988162B
ZA988162B ZA9808162A ZA988162A ZA988162B ZA 988162 B ZA988162 B ZA 988162B ZA 9808162 A ZA9808162 A ZA 9808162A ZA 988162 A ZA988162 A ZA 988162A ZA 988162 B ZA988162 B ZA 988162B
Authority
ZA
South Africa
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
ZA9808162A
Other languages
English (en)
Inventor
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Simon John Fawcett Macdonald
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA988162B publication Critical patent/ZA988162B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9808162A 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. ZA988162B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9719187.8A GB9719187D0 (en) 1997-09-09 1997-09-09 Compounds

Publications (1)

Publication Number Publication Date
ZA988162B true ZA988162B (en) 2000-03-22

Family

ID=10818820

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9808162A ZA988162B (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.

Country Status (24)

Country Link
US (1) US6228853B1 (et)
EP (1) EP1019406A1 (et)
JP (1) JP2001515902A (et)
KR (1) KR20010023830A (et)
CN (1) CN1278821A (et)
AP (1) AP2000001760A0 (et)
AU (1) AU9536098A (et)
BR (1) BR9811651A (et)
CA (1) CA2303249A1 (et)
EA (1) EA200000205A1 (et)
EE (1) EE200000137A (et)
GB (1) GB9719187D0 (et)
HR (1) HRP20000136A2 (et)
HU (1) HUP0003475A3 (et)
ID (1) ID24364A (et)
IL (1) IL134935A0 (et)
IS (1) IS5394A (et)
MA (1) MA26544A1 (et)
NO (1) NO20001200L (et)
PL (1) PL339186A1 (et)
SK (1) SK3242000A3 (et)
TR (1) TR200001026T2 (et)
WO (1) WO1999012931A1 (et)
ZA (1) ZA988162B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US7745226B2 (en) 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
CN102812356B (zh) 2009-12-11 2017-08-08 奎斯特诊断投资公司 多重样品中的甾族化合物的质谱法
US20110240840A1 (en) 2009-12-11 2011-10-06 Quest Diagnostics Investments Incorporated Mass spectrometric determination of cookson-derivatized, non-metabolized vitamin d
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
WO2021209740A1 (en) 2020-04-16 2021-10-21 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection
EP4419102A1 (en) 2021-10-20 2024-08-28 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes
GB8512230D0 (en) 1985-05-14 1985-06-19 Shell Internationale Researche Preparation of carboxylic acid salt
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
ES2205072T3 (es) 1996-01-03 2004-05-01 Smithkline Beecham Plc Derivados carbamoiloxi de mutilina y su uso como agentes antibacterianos.
EE9800335A (et) 1996-03-28 1999-04-15 Glaxo Group Limited Pürrolopürrolooni derivaadid kui neutrofiilelastaasi inhibiitorid

Also Published As

Publication number Publication date
GB9719187D0 (en) 1997-11-12
CN1278821A (zh) 2001-01-03
WO1999012931A1 (en) 1999-03-18
HRP20000136A2 (en) 2000-08-31
CA2303249A1 (en) 1999-03-18
JP2001515902A (ja) 2001-09-25
NO20001200D0 (no) 2000-03-08
EP1019406A1 (en) 2000-07-19
AP2000001760A0 (en) 2000-03-31
EA200000205A1 (ru) 2000-10-30
AU9536098A (en) 1999-03-29
ID24364A (id) 2000-07-13
MA26544A1 (fr) 2004-12-20
NO20001200L (no) 2000-05-08
BR9811651A (pt) 2000-08-08
TR200001026T2 (tr) 2000-09-21
KR20010023830A (ko) 2001-03-26
PL339186A1 (en) 2000-12-04
US6228853B1 (en) 2001-05-08
HUP0003475A2 (hu) 2001-09-28
SK3242000A3 (en) 2001-03-12
IL134935A0 (en) 2001-05-20
IS5394A (is) 2000-03-03
HUP0003475A3 (en) 2002-01-28
EE200000137A (et) 2001-02-15

Similar Documents

Publication Publication Date Title
ZA200006577B (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors.
SI1174431T1 (sl) 2-fenil-substituirani imidazotriazinoni kot inhibitorji fosfodiesteraze
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
AU6477498A (en) Scale inhibitors
EG23756A (en) D-proline derivatives
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
IL125859A0 (en) Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase
AU3935895A (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
AU5991699A (en) Quinolizinones as integrin inhibitors
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
IL134791A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
IL139490A0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
AU9059798A (en) Urokinase inhibitors
AU5652698A (en) (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
ZA975986B (en) N-alkoxyadenine derivatives acting as cytokine inhibitors.
ZA978307B (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase.
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
ZA988162B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
ZA9810039B (en) Azoline derivatives
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
ID23866A (id) Komposisi untuk menyelamatkan beras terhadap asetoklor
HK1026420A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1026210A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1016170A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase